NCT06527365: Safety and Efficacy of VDPHL01 in Males and Females With AGA
- State
- Under way
- Phase
- Phase 2
- People
- 70 planned
- Started
- 8 Jul 2024
- Primary completion
- Aug 2026
- Arms
- VDPHL01 Tablet
- Results
- None posted
- 8 Jul 2024: Trial started
- 30 Jul 2024: Trial registered